KBC Securities - CTP NV (CTPNV) ... Morning Notes : HYL BB, CTPNV NA, SYENS BB

Report

KBC Securities

Hilde Van Boxstael ...

Jacob Mekhael
Wim Hoste
Wim Lewi

Morning Notes : HYL BB, CTPNV NA, SYENS BB

: HYL BB, CTPNV NA, SYENS BB

30/09/2024 1 EN

Underlyings

CTP NV

See profile

NL00150006R6 Euronext Amsterdam Netherlands

Hyloris Pharmaceuticals

See profile

BE0974363955 Euronext Brussels Belgium

SYENSQO

See profile

BE0974464977 Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Hilde Van Boxstael

Jacob Mekhael

Wim Hoste

Wim Lewi

Other Reports on these Companies

GlobeNewsWire

Syensqo - Acquisition of own shares

Syensqo - Acquisition of own shares Acquisition of own shares Brussels, Belgium – September 30, 2024 - 17:45 CEST In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code of Companies and Associations, Syensqo SA (“Syensqo” or the “Company”) hereby discloses certain information in relation to its Share Buyback Program, announced on 25 June 2024. In the framework of this Share Buyback Program, covering the buyback of a maximum of 983,000 Syensqo shares, Syensqo announces that it has repurchased 49,303 Syensqo shares in the period from 23 September u...

34m 34m 1 EN

GlobeNewsWire

Syensqo - Acquisition d'actions propres

Syensqo - Acquisition d'actions propres Acquisition d'actions propres Bruxelles, Belgique – 30 septembre 2024 - 17:45 CEST Conformément à l'article 8:4 de l'Arrêté Royal du 29 avril 2019 portant exécution du Code belge des Sociétés et des Associations, Syensqo SA ("Syensqo" ou la "Société") publie certaines informations relatives à son Programme de Rachat d'Actions Propres, annoncé le 25 juin 2024. Dans le cadre de ce Programme de Rachat d'Actions Propres, couvrant l’acquisition d'un maximum de 983 000 actions Syensqo, Syensqo annonce qu'elle a acquis 49.303 actions Syensqo au co...

34m 34m 1 EN

GlobeNewsWire

Syensqo - Verwerving van eigen aandelen

Syensqo - Verwerving van eigen aandelen Verwerving van eigen aandelen Brussel, België - 30 september 2024 – 17u45 CEST In overeenstemming met artikel 8:4 van het Koninklijk Besluit van 29 april 2019 tot uitvoering van het Belgisch Wetboek van Vennootschappen en Verenigingen, maakt Syensqo NV (“Syensqo” of de “Vennootschap”) hierbij bepaalde informatie bekend in verband met zijn Aandelen Inkoopprogramma, aangekondigd op 25 juni 2024. In het kader van dit Aandelen Inkoopprogramma, dat voorziet in de inkoop van maximaal 983 000 Syensqo-aandelen, kondigt Syensqo aan dat het 49,303 Sy...

34m 34m 1 EN

Hyloris Hyloris' partner AFT out licences Maxigesic IV in China

Hyloris announced that its partner AFT Pharmaceuticals has signed an exclusive licensing agreement for Maxigesic IV (1000mg paracetamol with 300mg ibuprofen) for China with a subsidiary of Xizang Weixinkang Pharmaceutical. Hyloris will be eligible for a share of the $300K upfront received by AFT, as well as milestones and royalties. Details on the development plans in China have not been disclosed, though we believe a local trial would likely be required to gain approval by the Chinese NMPA (national medical products administration). We plan to incorporate this new region in our model at a lat...

9h / 36m 9h / 36m 1 EN

Wim Lewi

Wim Lewi

CTP The high road to CEE, fasten seatbelts please

CTP hosted its CMD in Romania (2nd market) with a side trip to Serbia. CTP warehouses look very similar everywhere, but meeting the local teams offers a lot of additional info. The visit to the Bucharest-West park perfectly illustrated how the CTP machine ticks. CTP explains their high Yield on Cost (YoC) by “being their own contractor”. As most contractors have low margins, we believe the situation is more complex. In a nutshell, CTP builds parks like US farms grow their crops: large scale surfaces. CTP can develop and time its pipeline much more efficiently. The most important barrier is obt...

9h / 50m 9h / 50m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : HYL BB, CTPNV NA, SYENS BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Syensqo - Acquisition of own shares

Syensqo - Acquisition d'actions propres

Syensqo - Verwerving van eigen aandelen

Hyloris Hyloris' partner AFT out licences Maxigesic IV in China

CTP The high road to CEE, fasten seatbelts please

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe